semaglutide and ibd Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy safety semaglutide and inflammatory bowel disease – The bi-directional relationship between inflammatory

GLP-1s are not without side effects (nausea, muscle mass loss) and, beyond that, broader concerns about long-term use

AylancVTomsARusso-AlmeidaPFalcoSIVilas-BoasM

Muscle Growth and Lean Mass Retention This peptide combo enhances IGF-1 production, which supports muscle protein synthesis and helps build and retain lean mass, especially in calorie deficits or during cutting phases

Lilly's Triple Agonist, Retatrutide, Demonstrated Significant Reductions in A1C and Weight in First Phase 3 Trial for Treatment of Type 2 Diabetes

While some complementary approachesincluding selenium supplementation, dietary modifications, and stress reductionhave been studied, evidence for their efficacy remains limited and inconsistent